# The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery

> **NCT07458256** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 190 (estimated)

## Conditions studied

- Laparoscopic Surgery
- Liposomal Bupivacaine
- Local Infiltration

## Interventions

- **DRUG:** Bupivacaine hydrochloride
- **DRUG:** Liposomal bupivacaine plus bupivacaine

## Key facts

- **NCT ID:** NCT07458256
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-10
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07458256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07458256, "The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07458256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*